Global Hemophilia Treatment Market 2016: Industry Analysis, Statistics, Reviews and Forecast 2022
Hemophilia is a hereditary genetic disorder which impairs body's ability to control coagulation or blood clotting. In this disease, clotting factors control bleeding from a broken vessel is deficient; therefore, coagulation does not occur. Of the two types of Hemophilia, Hemophilia A has higher prevalence compared to the other variant Hemophilia B. . Acquired Hemophilia is a rare non genetic form of Hemophilia in which autoantibodies develop against the plasma coagulation factor. The development of novel coagulating factors and technological...
View full press release